Increased immunoreactivity of transforming growth factor-β in human kidney transplants

Transplant Immunology

Volumn 4, Issue 3, 1996, Pages 209-214

  Lantz, Ingrid ^a   Dimény, Emöke ^b   Larsson, Erik ^b   Fellström, Bengt ^b   Funa, Keiko ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTERSTITIUM; KIDNEY BLOOD VESSEL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0030248755     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80019-0     Document Type: Article

References (28)

1. 1 Fellström BC, Larsson E. Pathogenesis and treatment perspectives of chronic graft rejection (CVR). Immunol Rev 1993; 134: 83-98.
2. 2 Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular vessel wall cells related to the development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989; 21: 3677-84.
3. 3 Kirk AD, Bollinger RR, Finn OJ. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol 1995; 43: 113-28.
4. 4 Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565-72.
5. 5 Nathan C, Sporn MB. Cytokines in context. J Cell Biol 1991; 113: 981-86.
6. 6 Blanche G, Gianello P, Germana S, Baetscher M, Sachs DH, LeGuern C. Molecular identification of porcine interleukin 10: regulation of expression in a kidney allograft model. Proc Natl Acad Sci USA 1995; 92: 2800-804.
7. 7 Qin L, Chavin KD, Ding Y et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta1 or vIL-10. Transplantation 1995; 59: 809-16.
8. 8 Kehrl JH. Transforming growth fasctor-β: an important mediator of immunoregulation. Int J Cell Cloning 1991; 9: 438-50.
9. 9 Border WA, Ruoslahti E. Transforming growth factor-b in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1.
10. 10 Roberts AB, Sporn MB, Assoian RK et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167-71.
11. 11 Kanzaki T, Olofsson A, Morén A et al. TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 1990; 61: 1051-61.
12. 12 Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engström U, Heldin C-H. Transforming growth factor-β1, -β2 and -β3 secreted by a human glioblastoma cell line: identification of small and different forms of large latent complexes. J Biol Chem 1992; 267: 19482-88.
13. 13 Kehrl JH, Roberts AB, Wakefield LM, Jakowlew SB, Sporn MB, Fauci AS. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986; 137: 3855-60.
14. 14 Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-50.
15. 15 Ignotz RA, Massagué J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J Biol Chem 1986; 261: 4337-45.
16. 16 Edwards DR, Murphy G, Reynolds JJ et al. Transforming growth factor beta modulates the expression of collagenase and metallo-proteinase inhibitor. EMBO J 1987; 6: 1899-904.
17. 17 Bortell R, Owen TA, Ignotz R, Stein GS, Stein JL. TGF beta1 prevents the down-regulation of type I procollagen, fibronectin, and TGF beta1 gene expression associated with 3T3-L1 pre-adipocyte differentiation. J Cell Biochem 1994; 54: 256-63.
18. 18 Waltenberger J. Transforming growth factor-β induction in carcinoid heart disease. In: Cummins P ed. Growth factors and the cardiovascular system. Dordrecht: Kluwer Academic, 1993: 311-20.
19. 19 Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
20. 20 Shankland SJ, Scholey JW, Ly H, Thai K. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 1994; 46: 430-42.
21. 21 Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995; 44: 1139-46.
22. 22 Waltenberger J, Wanders A, Fellström B, Miyazono K, Heldin C-H, Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 1993; 151: 1147-57.
23. 23 Ahuja SS, Shrivastav S, Danielpour D, Balow JE, Boumpas DT. Regulation of transforming growth factor-beta1 and its receptor by cyclosporine in human T lymphocytes. Transplantation 1995; 60: 718-23.
24. 24 Waltenberger J, Akyürek ML, Aurivillius M et al. Ischemia-induced transplant arteriosclerosis in the rat. Induction of peptide growth factor expression. Arterioscler Thromb Vasc Biol submitted.
25. 25 Flaumenhaft R, Abe M, Sato Y et al. Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993; 120: 995-1002.
26. 26 Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371-74.
27. 27 Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-64.
28. 28 Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-beta1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-27.